Biocartis appoints Dr Nayan Gregory Parekh as its new chief executive

pharmafile | December 1, 2011 | Appointment | Business Services, Research and Development, Sales and Marketing Biocartis 

Biocartis, a Swiss company developing compact molecular diagnostic systems, has announced the appointment of Dr Nayan Gregory Parekh as its new chief executive officer.

Parekh brings to Biocartis a wealth of pharma and biotechnology industry experience and has been an executive director of the company’s board since April 2011.

Rudi Pauwels, co-founder of Biocartis and current chief executive, will become executive chairman.

Dr Parekh said: “With its experienced senior leadership team, the recent $100 million fundraising, its unique consortium business model and the committed support of its key strategic collaborators, Biocartis is well placed to introduce several molecular diagnostics systems that will deliver high-quality data in a timely manner and improve healthcare outcomes.”

Advertisement

Related Content

Biocartis announces breast cancer research collaboration with US Mayo Clinic

Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop …

The Gateway to Local Adoption Series

Latest content